Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025.
Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 U.S. States, 2004-2023.
Impact of Serotype Uncertainty on Adult Pneumococcal Vaccine Options: A Value of Information Analysis
Prevalence and outcomes of bacterial co-detections by blood culture among children and adults hospitalized with laboratory-confirmed influenza, Influenza Hospitalization Surveillance Network, 2022-2024.
Trends in Incidence and Epidemiology of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005–2022
Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults
Respiratory syncytial virus: an under-recognized healthcare-associated infection.
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates.
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
Clinical Outcomes of US Adults Hospitalized for COVID-19 and Influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021-September 2022.
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older.
Changes in the cost-effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adults.
Meningococcal Disease in Persons With HIV Reported Through Active Surveillance in the United States, 2009-2019.
Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic.
Lessons Learned From Implementation of Mpox Surveillance During an Outbreak Response in Tennessee, 2022.
Estimating the Burden of Influenza Hospitalizations Across Multiple Seasons Using Capture-Recapture.
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014–2020
Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
Efficacy of a 4-Antigen <i>Staphylococcus aureus</i> Vaccine in Spinal Surgery: The <i>STaphylococcus aureus</i> suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014-2020.
Epidemiology of Invasive Nontypeable <i>Haemophilus influenzae</i> Disease<i>—</i>United States, 2008–2019
Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19
Epidemiology of Invasive Nontypeable Haemophilus influenzae Disease-United States, 2008-2019.
Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020-April 2022.
Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults.